Children suffering from a form of autism called ADNP syndrome may benefit from an experimental drug designed to treat Alzheimer's disease.
Genomic autism-related ADNP mutations were found in postmortem olfactory bulbs and hippocampi of Alzheimer's patients.
Study highlights the neuroprotective potential of SKIP.
Findings could help physicians screen for, and effectively diagnose Alzheimer's disease, researchers say.
A new study reports researchers have discovered a new molecular target which is essential for neuroplasticity.
Inhibition of a basic cellular process could contribute to schizophrenia, a new study reports.
Researchers develop a protein called NAP which protects and restores nerve cell communication in some neurodegenerative diseases.
